Market Trend
Short Term | Medium Term | ||
Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
Stock | Haleon plc | Mixed | Mixed |
Stockmoo Score
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition. |
|
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Investment Style | Large Core |
No data within this time range.
No data within this time range.
TTM Dividend Yield | 1.76% |
1Y Average Dividend Yield | 1.26% |
Expected Next Dividend Payment | Oct 2024 |
Ex Date | Announcement Date | Payment Date | Details |
---|---|---|---|
14 Mar 2024 | 29 Feb 2024 | 16 May 2024 | 0.1063524 Cash |
24 Aug 2023 | 02 Aug 2023 | 05 Oct 2023 | 0.0459936 Cash |
16 Mar 2023 | 02 Mar 2023 | 27 Apr 2023 | 0.0577344 Cash |
Annual Dividend Yield
Year | Annual Dividend ($) | Frequency/Year | Yield % |
---|---|---|---|
2024 | 0.106 | 1 | 1.23 |
2023 | 0.104 | 2 | 1.26 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |